Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-30

FDA Approved: BINOSTO — Supplemental Application (Radius Health, Inc.)

View source ↗

Summary

FDA approved Radius Health's supplemental application for BINOSTO (alendronate sodium), resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BINOSTO (ALENDRONATE SODIUM)

Snippet

SUPPL AP for BINOSTO (ALENDRONATE SODIUM)